Vanillin

Vanillin

SCHEMBL20549709

COc1cc(C=O)ccc1O.O

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Vanillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 known ✓ P09917 3/20 0.62
EGFR known ✓ P00533 2/20 0.60
MEN1 known ✓ O00255 1/20 0.58
HDAC3 known ✓ O15379 1/20 0.58
THRB known ✓ P10828 1/20 0.58
VDR known ✓ P11473 1/20 0.58
PTGS1 known ✓ P23219 1/20 0.58
PTGS2 known ✓ P35354 1/20 0.58
MMP13 known ✓ P45452 1/20 0.58
GSK3B known ✓ P49841 1/20 0.58
HDAC4 known ✓ P56524 1/20 0.58
HDAC1 known ✓ Q13547 1/20 0.58
HDAC7 known ✓ Q8WUI4 1/20 0.58
HDAC2 known ✓ Q92769 1/20 0.58
HDAC10 known ✓ Q969S8 1/20 0.58
HDAC11 known ✓ Q96DB2 1/20 0.58
HDAC8 known ✓ Q9BY41 1/20 0.58
HDAC6 known ✓ Q9UBN7 1/20 0.58
HDAC9 known ✓ Q9UKV0 1/20 0.58
HDAC5 known ✓ Q9UQL6 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vanillin SCHEMBL29697601 1.00 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL1213 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL720723 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL29354839 0.98 ALDH1A1 (1.00) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL8853913 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL19411839 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL19149274 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL2907529 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL8854077 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1
Vanillin SCHEMBL4442606 0.96 ALDH1A1 (0.96) ALDH1A1HPGDTDP1TRIM24ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689579-B2 Flame-retardant vanillin-derived small molecules INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-06-23 US disclosed
US-10689578-B2 Flame-retardant vanillin-derived cross-linkers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-06-23 US disclosed
US-20190177619-A1 FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-06-13 US disclosed
US-20190136137-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2019-05-09 US disclosed
US-10167427-B2 Flame-retardant vanillin-derived cross-linkers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2019-01-01 US disclosed
US-20180320079-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-11-08 US disclosed
US-20180320076-A1 FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-11-08 US disclosed
US-20180320074-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177619-A1 FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES PFAS, PTK2, VCL ALOX5 2203/4885EGFR 2858/4885MEN1 4837/4885
US-20190136137-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS PFAS, VCL, PFKFB2 ALOX5 1135/4885EGFR 3060/4885MEN1 4866/4885
US-20180320074-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS PFAS, VCL, PFKFB2 ALOX5 1135/4885EGFR 3060/4885MEN1 4866/4885
US-10167427-B2 Flame-retardant vanillin-derived cross-linkers PFAS, VCL, PFKFB2 ALOX5 1135/4885EGFR 3060/4885MEN1 4866/4885
US-10689579-B2 Flame-retardant vanillin-derived small molecules PFAS, PTK2, VCL ALOX5 2203/4885EGFR 2858/4885MEN1 4837/4885
US-20180320076-A1 FLAME-RETARDANT VANILLIN-DERIVED SMALL MOLECULES PFAS, PTK2, VCL ALOX5 2203/4885EGFR 2858/4885MEN1 4837/4885
US-20180320079-A1 FLAME-RETARDANT VANILLIN-DERIVED CROSS-LINKERS PFAS, VCL, PFKFB2 ALOX5 1135/4885EGFR 3060/4885MEN1 4866/4885
US-10689578-B2 Flame-retardant vanillin-derived cross-linkers PFAS, VCL, PFKFB2 ALOX5 1135/4885EGFR 3060/4885MEN1 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.